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Background and the purpose of study: Concerning the different effects of essential oils from Nepeta genus on
the central nervous system including pain killing effect, this study was designed to evaluate the antinociceptive and
anti-inflammatory effects of essential oil of Nepeta pogonosperma Jamzad et Assadi (NP), a recently identified
species.
Methods: Air-dried aerial parts of NP were hydrodistillated and GC-MS analysis of obtained essential oil was
conducted. Total 24 male Wister rats weighing 225 ± 25 gm were studied. Essential oil of NP was administered
intraperitoneally at the doses of 50 mg/kg, 100 mg/kg and 200 mg/kg for the experimental groups. Control rats
received equal volume (2 ml/kg) of normal saline. Antinociception was assessed by tail flick test (after 30 minutes)
and formalin test (for further 60 minutes). Then the animal was sacrificed and the paw edema was measured
using a water plethysmometer.
Results: 4aα,7α,7aβ-nepetalactone and 1,8-cineole were found as the main concentrated components of NP
essential oil. All the doses of NP showed antinociception. NP 200 mg/kg reduced the pain sensation in tail flick
(p <0.01) and formalin test (p <0.001 in both phases). In paw edema test, NP 100 and 200 mg/kg significantly
reduced the inflammation (p <0.01 and p <0.05).
Conclusion: This study reveals that the essential oil of NP may minimize both the acute and chronic forms of
nociception and may have potent role against inflammation, but the dose should be maintained precisely to
obtain the intended effect.
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Nepeta L. (from Lamiaceae) contains about 300 species,
which are distributed in central and southern Europe
and in near East, central and southern Asia also. Within
them Iran is one of the centers of origin of this genus
with 75 species and approximately 53% endemics [1].
The diversity, species richness and variation as well as
chemical properties have led to much research into this
genus. The extracts of many Nepeta species are used in
domestic medicine. N. cataria L., commonly known as* Correspondence: taskinadr@gmail.com
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reproduction in any medium, provided the orcatnip, is the most intensively studied species [2], which
is used as a fortifier, a disinfectant and a cure for colds.
The extracts of some species are also used because of
their diuretic properties and slight bacteriostatic activity,
and also in ointments to heal skin disorders of eczema
type [3]. Some of the species are widely used in folk
medicine because of their expectorant, antiseptic, anti-
tussive, antiasthmatic and febrifuge activities [4-6]. The
beverages and infusion prepared from the aerial parts of
Nepeta crispa Willd. were traditionally used as sedative,
relaxant, carminative and also restorative tonic for ner-
vous and respiratory disorders [7]. It has also been
shown to have antimicrobial (N. meyeri) and anxiolytic
(N. persica) properties [8].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perma Jamzad et Assadi, which was identified as new
species in 1984 [6]. The essential oil composition of its
aerial parts has been reported [9]. The main components
of its essential oil were 4aα, 7α, 7aβ-Nepetalactone
(57.6%) and 1,8-cineol (26.4%). The dried aerial parts of
other species of Nepeta were also shown to contain both
of these components in different proportion in their
essential oil [7,10].
The most important constituent of the essential oil of
this Nepeta species, 1, 8-cineol, an oxygenated monoter-
pene, showed inhibitory effect on carrageenan induced
paw edema and cotton-pellet induced granuloma in rats
[11]. It has also been stated that this terpenoid oxide has
strong inhibitory effect on cytokine production in cul-
tured human lymphocytes and monocytes [12]. More-
over, its steroid sparing capacity in bronchial asthma
was also determined [13]. A recent report on the essen-
tial oil of Rosmarinus officinalis L. (a endemic plant in
Mexico), which contains 8.58% 1,8-cineole, showed a
dose dependent antinociceptive effect in rat model [14].
In addition different isomers of Nepetalactones were
reported to have considerable sedative and analgesic ac-
tivity. 4aα, 7α, 7aβ-Nepetalactone, the key constituent of
Nepeta ceasarea Boiss, was suggested to have a specific
opioid receptor agonistic activity [15]. Again the catnip
oil prepared from Nepeta cataria showed to have 40%
nepetalactone, which was responsible for significant
increase in the hexobarbital sleeping time in mice [16].
Different species of Nepeta genus are reported to con-
tain antinociceptive and anti-inflammatory effects. In an
study on Nepeta cataria essential oil showed of having
79.27% of nepetalactone which might be responsible
for its potent antinociceptive and anti-inflammatory
activity in mice model [17]. Moreover, extract and frac-
tions from Nepeta sibthorpil have been reported to have
anti-inflammatory activity in carrageenan induced paw
edema model in rat [18]. Recently we reported the anal-
gesic and anti-inflammatory effects of Nepeta crispa
Willd. in animal models [19]. On the basis of these
diversified biological activities of the Nepeta species and
their use in folk medicine, this study was designed to
evaluate antinociceptive and anti-inflammatory effects
of a newly introduced species, Nepeta pogonosperma.
We evaluated the antinociceptive effect in both acute
and chronic pain models and also investigated its anti-
inflammatory activity in an animal paw edema model.
Materials and methods
Plant materials
The aerial flowering parts of Nepeta pogonosperma Jam-
zad & Assadi were collected from its wild locality in
Qazvin province on 20 May, 2008. The plant was identi-
fied by A. Sonboli and a voucher specimen (MPH-1917)was deposited in herbarium of Medicinal Plants and
Drugs Research Institute (MPH) of Shahid Beheshti Uni-
versity, Tehran, Iran.
Air-dried aerial parts (100 g) of Nepeta pogonosperma
were subjected to hydrodistillation using a Clevenger-
type apparatus. The essential oil was dried over anhyd-
rous sodium sulfate and stored in sealed vials. The oil
was stored at 4°C until the time of analysis and tests.
GC-MS analysis of the essential oil was conducted on a
Thermoquest-Finnigan Trace GC-MS system equipped
with a fused silica DB-1 capillary column (60 m ×
0.32 mm i.d., film thickness 0.25 μm). Helium was used
as the carrier gas at the constant flow of 1.1 ml/min.
The oven temperature was 60°C rising to 250°C at a rate
of 5°C/min, then held at 250°C for 10 min; transfer line
temperature, 250°C; split ratio was 1/50. The quadrupole
mass spectrometer was scanned over the 45–465 amu
with an ionizing voltage of 70 eV and an ionization
current of 150 μA. The injector and detector (FID) tem-
peratures were kept at 250°C and 280°C, respectively.
Retention indices (RI) for all constituents were cal-
culated according to Van den Dool approach, using n-
alkanes (C6 – C24) as standards and the essential oil on a
DB-1 column under the same chromatographic condi-
tions. The identification of the components was made
based on comparison of their mass spectra with those of
the internal computer reference mass spectra libraries
(Wiley 7.0), as well as by comparison of their retention
indices with data published.Animals
Twenty four (24) male Wister rats weighing 225±25 g
obtained from the Pasteur Institute, Karaj, Iran, were used.
They were housed in plexiglass cages as 6 animals per cage
with room temperature 24±2°C under a 12 hour light/
dark cycle and had free access to water and pellet. The rats
were accustomed to the laboratory condition for 4 days
before commencement of the experiments. Efforts were
made to minimize the number of animals used and their
sufferings. All research and animal care procedures were
performed according to the international guidelines on the
use of laboratory animals and on the basis of codes for
ethics in animal research in Tarbiat Modares UniversityDrug administration
Animals were treated intraperitoneally (i.p.) with normal
saline for the control group or the essential oil of Nepeta
pogonosperma at the doses of 50, 100 or 200 mg/kg for
the experimental groups. The doses were selected based
on our previous report on the antinociceptive effects of
N. crispa [19]. An equal volume of injection of essential
oil or normal saline (200 μl/100 g of body weight) was
applied for all animals.
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Acute antinociceptive effect was assessed based on the
method introduced by D’Amour and Smith [20] using a
tail-flick apparatus (Harvard Apparatus). The baseline
latency was obtained using the mean of similar three
consecutive measurements. Normal saline (for control
rats) or essential oil (for experimental groups) were
injected i.p. immediately after the third pre-drug
measurement. Again, test latency was determined after
30 minutes of saline or oil administration (mean of
3 measurements). To minimize tissue damage, a maxi-
mum latency of 10 seconds was imposed. Antinoci-
ceptive effect was calculated as percent of maximum
possible effect (% MPE), as follows [21]:
% MPE ¼ TL BLð Þ= CT BLð Þ½   100
TL=Test latency; BL=Baseline latency; CT=Cut-off time.
Formalin test
The formalin test was carried out in a plexiglass obser-
vation box, with a mirror placed under the floor (at a
45o angle) to allow a clear view of the paws. Immediately
after the recording of the 3rd latency time of the tail
flick test, 50 μl of 2% formalin was injected subcutane-
ously into the plantar aspect of the rat’s right hind paw.
The animal was then placed in the observation cage and
pain behaviors were recorded for 60 minutes. Nocicep-
tion was rated using a modification of the original for-
malin test protocol [22]. Briefly, the pain scoring
measurements were as follows: 0 = normal weight bear-
ing on the injected paw; 1 = limping during locomotion
or resting the paw lightly on the floor; 2 = elevation of
the injected paw; and 3 = licking or biting of the injected
paw. The first 5 minutes was considered as early phase
and minutes 16 to 60 were considered as the late phase
of formalin test [23]. The different behavioral parameters
including jerking, flexing and licking were took out from
the records as total counts per 5 minutes or total dur-
ation in seconds per 5 minutes, respectively.
Anti-inflammatory test
Anti-inflammatory effects of the essential oil were deter-
mined by the formalin-induced paw edema model. The
amount of paw edema caused by intra-plantar injection
of 2% formalin was used as an indicator of inflammation
severity. Following 60 minutes of recording the pain
behaviors (about 90 minutes after the i.p administration
of the essential oil or saline), the animal was sacrificed.
Then the volume of the animals’ right and left hindpaws
were measured using a water plethysmometer as men-
tioned by Fereidoni et al. 2001 [24]. Right paw volume
was subtracted by left paw volume to obtain the net
edema volume.The rats were not tested more than once and all the
experiments were carried out in between 9:00 and 15:00,
to minimize the possible influence of circadian changes
on rat behavior.
Statistical analysis
Data obtained for different pain behavior and edema
were scrutinized using one way analysis of variance
(ANOVA) followed by the Tukey post-hoc test. The
results are expressed as mean ± S.E.M and p <0.05 was
considered as significant difference of means.
Results
Essential oil composition
Although, the main components of Nepeta pogonos-
perma essential oil were reported to be 1,8-cineole and
4aα,7α,7aβ-nepetalactone, concerning the percentage
variations in previous reports and the seasonal and local
variations in the component of different plants, we
analyzed the composition of essential oil applied in this
study. Hydrodistilled essential oil of aerial parts of NP
gave pale yellow oil and forty-one components were
identified representing 97.5% of the total oil. Essential
oil compounds are presented in Table 1, where com-
pounds are listed in order of their elution on the DB-1
column. The main components of the oil were 4aα,7α,7aα
–nepetalactone (14.5%) and 1,8- cineole (31.2%) followed
by α-terpineol (5.4%), (E)-α-bisabolene (5.4%), terpinen-4-
ol (4.8%), linalool (4.5%) and β-pinene (3.5%).
Tail-flick test
The effects of 50, 100 and 200 mg/kg doses of NP essen-
tial oil on acute pain were evaluated using tail flick test.
As evaluated at 30 minutes post injection, 50 mg/kg
dose of NP did not produce any significant analgesia,
but the doses of 100 and 200 mg/kg of NP reduced the
acute thermal pain significantly (p <0.01 and p <0.001,
respectively). The percentage of maximum possible
effect (% MPE) of all the doses were compared to that of
the control and presented in Figure 1.
Formalin test
The effects of systemic i.p. administration of different
doses of the essential oil of NP on the early and late
phases of formalin test were observed. In both phases the
pain behaviors were separately analyzed as total jerking
frequency, licking duration and flexing duration.
As it is mentioned in Figure 2, in the first phase of for-
malin test 50, 100 and 200 mg/kg doses of NP reduced
the jerking frequency (p <0.001, in all doses), flexing
duration (p <0.05, p <0.05, p <0.01, respectively) and
licking duration (p <0.05, p <0.001, p <0.001, respect-
ively), significantly.
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2-methylbutyl 2-methylbutanoate 1093 0.7

















germacrene D 1475 0.2
(E)-α-bisabolene 1493 5.2
caryophyllene-oxide 1573 2.7






Total identified (35 comp.) 97.5%
Figure 1 Antinociceptive effects of different doses (i.p.) of the
essential oil of Nepeta pogonosperma (NP) on tail flick latency.
Comparison was done on percentage of maximum possible effect
(%MPE). Each bar represents the mean ± S.E.M. of 6 rats. * = p <0.05,
** = p <0.01 compared to control.
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mentioned in Figure 3, all the doses of NP reduced the
jerking frequency (p <0.001, in all doses), the flexing
duration (p <0.001, p <0.01, p <0.001, respectively) and
licking duration (p <0.01, p <0.05, p <0.001, respect-
ively), significantly.Anti-inflammatory effect
The amount of edema for formalin injected paw was
measured at the end of formalin test. As illustrated in
Figure 4, all the doses of the oil showed anti-
inflammatory effect in the paw edema model though it
was significant only in 100 (p <0.01) and 200 (p <0.05)
mg/kg of doses of NP.Discussion
The management of pain is probably one of the most
common and yet most difficult aspects in medical prac-
tice. Many improved analgesics and anti-inflammatory
agents have been developed, but there is considerable
opportunity for conceptual innovation.
We used heat induced and formalin induced pain
model for evaluating antinociceptive and formalin
induced paw edema model for anti-inflammatory effect
of Nepeta pogonosperma in experimental rats. Our data
demonstrated that the essential oil of this plant elicited
potent antinociceptive effects in rats subjected to both
the acute thermal (tail-flick) and chronic or persistent
formalin pain stimuli and strong anti-inflammatory
effect to formalin induced paw edema model.
The Tail flick test is one of the most appropriate tech-
niques to assess the acute somatosensory pain transmis-
sion by stimulating thermoreceptors in experimental
animal model [25]. King et al (1997) showed that this
test is sensitive to centrally acting analgesics and
Figure 2 Antinociceptive effects of different doses of the essential oil of Nepeta pogonosperma (NP) in the early phase of formalin test
(minutes 0 – 5). NP doses reduced different pain behaviors including jerking (A), flexing (B) and licking (C). Each bar symbolizes for mean ± S.E.
M. for 6 rats. * = p <0.05, ** = p <0.01, *** = p <0.001 compared to control.
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which was inhibited by a low dose of morphine [26].
Since our results mentioned potent analgesia in higher
two doses of NP in tail flick test, it may be commented
that the effective component(s) of this essential oil exertsits antinociceptive effect by modulating the pain trans-
mission in the central nervous system.
Formalin test is one of the appropriate methods for
producing and quantifying the chemical pain in the rat
model. Pain intensity in this test is dependent on some
Figure 3 Antinociceptive effect of different doses of the essential oil of Nepeta pogonosperma (NP) in the late phase of formalin test
(minutes 16 – 60). NP doses reduced all pain behaviors including jerking (A), flexing (B) and licking (C). Each bar symbolizes for mean ± S.E.M.
for 6 rats. * = p <0.05, ** = p <0.01, ***p <0.001 compared to control.
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converted to numerical values [22]. Subcutaneous injec-
tion of formalin induces hindpaw inflammation, which
leads to a response characterized by jerking, flexing
followed by licking of the affected hindlimb. This char-
acteristic response is considered to be a central nocicep-
tive model, and has been associated with increased levelsof chemical mediators in tissue fluids. The level of pain
in this model is sensitive to both centrally and peripher-
ally acting analgesics. In the present study, as the i.p.
administration of different doses of the essential oil of
NP inhibited both phases of pain response relative to
controls, it may be suggested that it has both the central
and peripheral antinociceptive effects. We checked for
Figure 4 Anti-inflammatory effects of different doses of the
essential oil of Nepeta pogonosperma (NP) in formalin-induced
paw edema model. Each bar represents for mean ± S.E.M., n = 6
(experimental) - 9 (control) rats, * = p <0.05, ** = p <0.01, compared
to control.
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reduced formalin induced edema. This finding proved
the peripheral antinociceptive effects of the oil bye
ameliorating the formalin induced inflammation. Com-
paring the antinociceptive and anti-inflammatory effects
of the lower dose (50 mg/kg), again makes the central
analgesic effect plausible. In the other word, the dose
which did not produce anti-inflammatory effect exerted
significant analgesic effect.
Similar to the previous report [9], NP essential oil con-
tained 1, 8-cineole and 4aα, 7α, 7aβ-Nepetalactone as
two major constituent. It has been suggested by many
investigators that 1, 8-cineole, the most important con-
stituent of NP essential oil has potent antinociceptive
[14] and anti-inflammatory activity [11,12]. In addition,
Aydin and colleagues (1998) suggested that 4aα, 7α, 7aβ-
Nepetalactone, might be responsible for the significant
analgesic activity and marked sedation in a rat model.
They also recommended this nepetalactone might have
specific opioid receptor subtype agonist activity [15].
Again in a behavioral study on rats a significant decrease
in performance was observed following i.p. administra-
tion of nepetalactone enriched fraction [16]. Further-
more the nepetalactone isomers were suggested to be
the responsible component of the anti-nociceptive and
anti-inflammatory actions of Nepeta cataria L. var.
citriodora (Becker) Balb. [17]. Moreover, the essential oil
of Nepeta crispa Willd. which contained 20.3% 4aα, 7α,
7aβ-Nepetalactone and 47.9% 1,8-cineole, showed strong
antibacterial, antifungal, antinociceptive and antiinflam-
matory activity [19,21]. This finding may support the po-
tent anti-inflammatory activity observed in our present
experiment. In a previous study, the analgesic activity of
the essential oil of Nepeta italica L. was showed to
be correlated with the amount of 1, 8-cineole [27]. In arecent animal study, cineole has been recommended to
reveal an antinociceptive activity comparable to that of
morphine in thermal analgesic stimuli [28]. Hence, both
of the components of NP essential oil, the 4aα, 7α, 7aβ-
Nepetalactone and 1, 8-cineole, may be responsible for
our experimental findings.
Conclusion
In conclusion, it may be recommended that the essential
oil of Nepeta pogonosperma may minimize both the
acute and chronic forms of nociception and may have
potent role against inflammation, but the dose should
be maintained precisely to obtain the intended effect.
Although, further experimental study is needed to eluci-
date the exact component and mechanism responsible
for these effects.
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